Bacterial display in combinatorial protein engineering

2011 ◽  
Vol 6 (9) ◽  
pp. 1115-1129 ◽  
Author(s):  
John Löfblom
2012 ◽  
Vol 8 (1) ◽  
pp. 139-145 ◽  
Author(s):  
Hanna Lindberg ◽  
Anna Johansson ◽  
Torleif Härd ◽  
Stefan Ståhl ◽  
John Löfblom

2002 ◽  
Vol 321 (4) ◽  
pp. 677-691 ◽  
Author(s):  
Paul E. O'Maille ◽  
Marina Bakhtina ◽  
Ming-Daw Tsai

2016 ◽  
Vol 29 (7) ◽  
pp. 263-270 ◽  
Author(s):  
Alexander Jarasch ◽  
Melanie Kopp ◽  
Evelyn Eggenstein ◽  
Antonia Richter ◽  
Michaela Gebauer ◽  
...  

Author(s):  
Paul E. O'Maille ◽  
Ming-Daw Tsai ◽  
Bryan T. Greenhagen ◽  
Joseph Chappell ◽  
Joseph P. Noel

2009 ◽  
Vol 37 (4) ◽  
pp. 717-721 ◽  
Author(s):  
Andrew J. Moss ◽  
Shikha Sharma ◽  
Nicholas P.J. Brindle

Growth factors provide key instructive cues for tissue formation and repair. However, many natural growth factors are limited in their usefulness for tissue engineering and regenerative applications by their poor retention at desired sites of action, short half-lives in vivo, pleiotropic actions and other features. In the present article, we review approaches to rational design of synthetic growth factors based on mechanisms of receptor activation. Such synthetic molecules can function as simplified ligands with potentially tunable specificity and action. Rational and combinatorial protein engineering techniques allow introduction of additional features into these synthetic growth molecules, as well as natural growth factors, which significantly enhance their therapeutic utility.


2010 ◽  
Vol 4 (3) ◽  
pp. 171-182 ◽  
Author(s):  
Nina Kronqvist ◽  
Magdalena Malm ◽  
Johan Rockberg ◽  
Barbara Hjelm ◽  
Mathias Uhlen ◽  
...  

2016 ◽  
Vol 473 (10) ◽  
pp. 1329-1341 ◽  
Author(s):  
Itay Cohen ◽  
Olumide Kayode ◽  
Alexandra Hockla ◽  
Banumathi Sankaran ◽  
Derek C. Radisky ◽  
...  

Cancer is a leading cause of morbidity and mortality worldwide. The results presented in the present study pave the way to develop new therapies targeting mesotrypsin, an enzyme that contributes to progression and metastasis of lung, prostate, breast and pancreatic cancers.


1999 ◽  
Vol 96 (7) ◽  
pp. 3562-3567 ◽  
Author(s):  
M. Ostermeier ◽  
A. E. Nixon ◽  
J. H. Shim ◽  
S. J. Benkovic

Sign in / Sign up

Export Citation Format

Share Document